Chronic Renal Failure — FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease
Citation(s)
Randomized Placebo Controlled Double-blind Trial in CKD Patients Not on Dialysis to Evaluate the Effect of Sevelamer Carbonate in the Control of FGF-23 Serum Levels and Its Consequences in the Evolution of PTH, Calcitriol and Mineral Metabolism Parameters Levels